You have chosen not to allow videos from the 3rd party streaming service (YouTube), if you would like to see these videos, please change your Privacy policy and cookie settings.
PGT-M conditions
The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.
When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.
If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.
Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.
Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.
| Condition name | Status | OMIM number | Documents |
|---|---|---|---|
| Spastic Ataxia 5, Autosomal Recessive (SPAX5) | approved | 614487 | |
| Spastic Ataxia 8, Autosomal Recessive with Hypo-Myelinating Leukodystrophy (SPAX8) | approved | 617560 | |
| Spastic Ataxia, Charlevoix-Saguenay Type (SACS) | approved | 270550 | |
| Spastic paraplegia (due to publishing limitations, we can't provide a link to the relevant minutes - please contact HFEA.Licensing@HFEA.gov.uk if you would like to be sent a copy) | approved | ||
| Spastic Paraplegia and Psychomotor Retardation with or without Seizures; SPPRS | approved | 616756 | |
| Spastic Tetraplegia, Thin Corpus Callosum, and Progressive Microcephaly (SPATCCM) | awaiting consideration | 616657 | |
| Spherocytosis, Type 1 (SPH1) | approved | 182900 | |
| Spherocytosis, Type 2 (SPH2) | approved | 616649 | |
| Spherocytosis, Type 3 (SPH3) | approved | 270970 | |
| Spherocytosis, Type 4 (SPH4) | approved | 612653 | |
| Spinal and Bulbar Muscular Atrophy X-linked (Kennedy disease) (in affected male embryos) | approved | 313200 | |
| Spinal Muscular Atrophy and Respiratory Distress (SMARD1) | approved | 604320 | |
| Spinal Muscular Atrophy with Congenital Bone Fractures 1 (SMABF1) | approved | 616866 | |
| Spinal Muscular Atrophy with Congenital Bone Fractures 2 (SMABF2) | approved | 616867 | |
| Spinal Muscular Atrophy, Type I (SMA1) | approved | 253300 | |
| Spinal Muscular Atrophy, Type II (SMA2) | approved | 253550 | |
| Spinal Muscular Atrophy, Type III (SMA3) | approved | 253400 | |
| Spinocerebella Ataxia 21 (SCA21) | approved | 607454 | |
| Spinocerebellar Ataxia 1 (SCA1) | approved | 164400 | |
| Spinocerebellar ataxia 10 (SCA10) | approved | 603516 | |
